Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Hercules Capital
HTGC
$3.17B
| $607K | ﹤0.01% |
45,888
-7,919
| -15% | -$108K |
|
3427
Nomura Holdings
NMR
$29B
| $606K | ﹤0.01% |
161,716
+99,457
| +160% | +$344K |
|
3428
Stratasys
SSYS
$767M
| $605K | ﹤0.01% |
51,015
-1,614
| -3% | -$21.5K |
|
|
KNTE
3429
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $604K | ﹤0.01% |
99,011
+1,690
| +2% | +$13.8K |
|
3430
Holley
HLLY
$362M
| $604K | ﹤0.01% |
284,769
+126,569
| +80% | +$398K |
|
|
BBIG
3431
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $603K | ﹤0.01% |
64,929
+32,699
| +101% | +$503K |
|
3432
iShares ESG Advanced MSCI EAFE ETF
DMXF
$974M
| $602K | ﹤0.01% |
11,091
+2,178
| +24% | +$113K |
|
3433
Voyager Therapeutics
VYGR
$197M
| $601K | ﹤0.01% |
98,488
-229
| -0.2% | -$1.3K |
|
3434
Expensify
EXFY
$202M
| $598K | ﹤0.01% |
67,698
+49,465
| +271% | +$554K |
|
|
WHWK
3435
Whitehawk Therapeutics
WHWK
$269M
| $596K | ﹤0.01% |
46,447
+672
| +1% | +$8.77K |
|
3436
Graham Corp
GHM
$1.33B
| $596K | ﹤0.01% |
61,907
+11,443
| +23% | +$106K |
|
3437
iShares North American Natural Resources ETF
IGE
$781M
| $596K | ﹤0.01% |
14,647
+929
| +7% | +$37.7K |
|
3438
LCNB Corp
LCNB
$281M
| $584K | ﹤0.01% |
32,443
-36,620
| -53% | -$640K |
|
3439
Torrid Holdings
CURV
$228M
| $583K | ﹤0.01% |
197,119
+153,609
| +353% | +$627K |
|
3440
Blue Bird Corp
BLBD
$2.04B
| $583K | ﹤0.01% |
54,412
-12,772
| -19% | -$128K |
|
|
DNMR
3441
DELISTED
Danimer Scientific, Inc.
DNMR
| $578K | ﹤0.01% |
8,079
-79
| -1% | -$7.47K |
|
3442
iShares S&P India Nifty 50 Index Fund
INDY
$562M
| $578K | ﹤0.01% |
13,668
-5,143
| -27% | -$225K |
|
3443
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $574K | ﹤0.01% |
20,482
-576
| -3% | -$15.7K |
|
|
RSVR
3444
Reservoir Media
RSVR
$646M
| $573K | ﹤0.01% |
95,918
+31,466
| +49% | +$180K |
|
3445
iShares MSCI Canada ETF
EWC
$6.55B
| $567K | ﹤0.01% |
17,310
-3,109
| -15% | -$103K |
|
3446
The RealReal
REAL
$1.33B
| $566K | ﹤0.01% |
453,017
+159,424
| +54% | +$229K |
|
3447
Humacyte
HUMA
$148M
| $565K | ﹤0.01% |
267,707
+197,931
| +284% | +$601K |
|
|
ALLK
3448
DELISTED
Allakos
ALLK
| $564K | ﹤0.01% |
66,934
-281
| -0.4% | -$1.95K |
|
|
KALV
3449
DELISTED
KalVista Pharmaceuticals
KALV
| $561K | ﹤0.01% |
83,018
+286
| +0.3% | +$1.53K |
|
|
KLRS
3450
Kalaris Therapeutics
KLRS
$92.4M
| $561K | ﹤0.01% |
4,755
-3
| -0.1% | -$509 |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.